XM n’offre pas ses services aux résidents des États-Unis d’Amérique.
A
A

Arkema


Actualités

Arkema, Fuller Smith & Turner, Siemens Energy

EUROPE RESEARCH ROUNDUP- Arkema, Fuller Smith & Turner, Siemens Energy May 9 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Arkema, Fuller Smith & Turner and Siemens Energy, on Thursday. HIGHLIGHTS * Arkema SA AKE.PA : HSBC raises target price to EUR 117 from EUR 107 * Bytes Technology Group Plc BYIT.L : Deutsche Bank initiates coverage with buy rating * Fuller Smith & Turner Plc FSTA.L : Deutsche Bank initiates coverage with buy
A
A
A
A
B
B
B
B
C
E
E
G
A
A
B
D
G

Arkema rises after Q1 core profit beat, confirmed guidance

BUZZ-Arkema rises after Q1 core profit beat, confirmed guidance ** Shares in Arkema AKE.PA rise 3.2% after the French speciality chemicals group reported better than expected Q1 core profit figures and confirmed short and mid-term guidance ** Arkema reported Q1 EBITDA at 350 million euros ($376.64 million), while analysts expected 341 million euros
A

French and Benelux stocks-Factors to watch

French and Benelux stocks-Factors to watch May 7 (Reuters) - Below are company-related news and stories from France and Benelux which could have an impact on the region's markets or individual stocks. ARKEMA AKE.PA The company confirmed its full-year guidance, saying the operating profit in the second quarter will likely be slightly higher compared to last year.
A
L
S
V
U

Arkema Confirms 2024 Guidance

BRIEF-Arkema Confirms 2024 Guidance May 7 (Reuters) - Arkema SA AKE.PA : Q1 SALES EUR 2.34 BILLION VERSUS CONSENSUS EUR 2.39 BILLION Q1 CURRENT NET INCOME EUR 138 MILLION VERSUS EUR 162 MILLION YEAR AGO Q1 EBITDA EUR 350 MILLION VERSUS CONSENSUS EUR 341 MILLION OUTLOOK: Q2 EBITDA EXPECTED SLIGHTLY HIGHER THAN LAST YEAR CONFIRMS 2024 GUIDANCE EBITDA
A

Dow Advances Strategic Focus With Sale Of Flexible Packaging Laminating Adhesives Business To Arkema

BRIEF-Dow Advances Strategic Focus With Sale Of Flexible Packaging Laminating Adhesives Business To Arkema May 2 (Reuters) - Dow Inc DOW.N : DOW ADVANCES STRATEGIC FOCUS WITH SALE OF FLEXIBLE PACKAGING LAMINATING ADHESIVES BUSINESS TO ARKEMA DOW INC - TRANSACTION VALUE IS $150 MILLION OR APPROXIMATELY 10 TIMES FORECASTED 2024 EBITDA DOW INC - TRANS
A
D

Arkema Acquires Dow's Flexible Packaging Laminating Adhesives Business

BRIEF-Arkema Acquires Dow's Flexible Packaging Laminating Adhesives Business May 2 (Reuters) - Arkema SA AKE.PA : ACQUIRES DOW'S FLEXIBLE PACKAGING LAMINATING ADHESIVES BUSINESS ACQUISITION WILL SIGNIFICANTLY EXPAND ARKEMA'S PORTFOLIO OF SOLUTIONS FOR FLEXIBLE PACKAGING ACQUIRED BUSINESS GENERATING ANNUAL SALES OF AROUND US$250 DEAL BASED ON AN ENT
A
D

Dassault Systemes, Husqvarna, Swedbank

EUROPE RESEARCH ROUNDUP-Dassault Systemes, Husqvarna, Swedbank April 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Dassault Systemes, Husqvarna and Swedbank on Friday. HIGHLIGHTS * AstraZeneca AZN.L : Deutsche Bank raises target price to 11000p from 10500p * Dassault Systemes DAST.PA : JP Morgan cuts to neutral from overweight * Husqvarna AB HUSQb.ST : Jefferies raises to buy from hold * London Stock Exchange Group LSEG.L : RB
A
A
A
A
A
A
A
A
A
A
A
B
B
B
B
B
D
D
F
H
I
N
R
S
V
A
A
A
B
B
B
E
F
S

Gerber, Perrigo sued over 'store-brand' infant formula prices

Gerber, Perrigo sued over 'store-brand' infant formula prices By Mike Scarcella April 23 (Reuters) - Infant formula makers Gerber and Perrigo have been hit with a proposed class-action lawsuit accusing them of scheming to artificially drive up prices for “store-brand” formula sold at Walmart, Walgreens and other retailers. The lawsuit , filed Monday in Alexandria, Virginia, federal court, said Perrigo violated antitrust law by illegally agreeing with Gerber to block competitors from cutting
A
W

Arkema Says Signed An Agreement To Buy Majority Stake Of Nearly 78% In Proionic

BRIEF-Arkema Says Signed An Agreement To Buy Majority Stake Of Nearly 78% In Proionic April 17 (Reuters) - Arkema SA AKE.PA : ARKEMA STRENGTHENS ITS RANGE OF SOLUTIONS FOR NEXT-GENERATION BATTERIES WITH THE ACQUISITION OF A MAJORITY STAKE IN PROIONIC ARKEMA SA - SIGNED AN AGREEMENT TO ACQUIRE A MAJORITY STAKE OF NEARLY 78% IN PROIONIC Source text f
A

U.S. STOCKS Hasbro, Eli Lilly, Bloom Energy

BUZZ-U.S. STOCKS ON THE MOVE-Hasbro, Eli Lilly, Bloom Energy Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes eyed a higher open on Wednesday bolstered by megacap growth stocks, while investors parsed corporate earnings and awaited commentary from Federal Reserve policymakers for clues on the state of the economy.
A
H
I
S
A
U
U
R

New PFAS lawsuit cites EPA's 'forever chemicals' drinking water rules

New PFAS lawsuit cites EPA's 'forever chemicals' drinking water rules By Clark Mindock April 15 (Reuters) - A new lawsuit filed by public drinking water systems in California against manufacturers of toxic "forever chemicals" is among the first to cite new Biden administration regulations that set strict limits for the chemicals in drinking water.
A
C

Arkema sites visited by investigators, chemicals group says

UPDATE 1-Arkema sites visited by investigators, chemicals group says Adds detail in paragraph 3 and 4 April 9 (Reuters) - Chemicals group Arkema AKE.PA said that investigators visited several of its sites on Tuesday, adding that it was cooperating with authorities. Regional broadcaster France 3 reported earlier on Tuesday that searches were under way at the Arkema and Daikin plants on the Pierre Benite site near the city of Lyon in southeastern France in connection with the release of PFAS (per-
A

Arkema sites visited by investigators, chemicals group says

Arkema sites visited by investigators, chemicals group says April 9 (Reuters) - Chemicals group Arkema AKE.PA said that investigators visited several of its sites on Tuesday, adding that it was cooperating with authorities. Regional broadcaster France 3 reported earlier on Tuesday that searches were under way at the Arkema and Daikin plants on the Pierre Benite site near the city of Lyon in southeastern France in connection with the release of PFAS (per-and polyfluoroalkyl substances) into the e
A

Arkema Spokesperson Confirms Investigators Visited Several Sites This Morning

BRIEF-Arkema Spokesperson Confirms Investigators Visited Several Sites This Morning April 9 (Reuters) - Arkema SA AKE.PA : WE CONFIRM INVESTIGATORS VISITED SEVERAL ARKEMA SITES THIS MORNING - SPOKESPERSON DURING THESE SEARCHES, WHICH ARE STILL IN PROGRESS, ARKEMA PROVIDED INVESTIGATORS WITH ALL REQUESTED INFORMATION -SPOKESPERSON THE GROUP CONTINUE
A

Azelis, Drax Group, Rentokil Initial

EUROPE RESEARCH ROUNDUP-Azelis, Drax Group, Rentokil Initial April 8 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Azelis, Drax Group and Rentokil Initial on Monday. HIGHLIGHTS * Azelis AZE.BR : JP Morgan raises target price to EUR 27 from EUR 25.5 * Drax Group Plc DRX.L : HSBC raises target price to 500p from 470p * Rentokil Initial RTO.L : HSBC cuts target price to 480p from 495p * Volvo AB VOLVb.ST : Jefferies raises to buy fr
A
A
A
A
B
B
B
C
C
C
D
D
E
G
G
H
H
H
K
L
L
R
A
A
D
F

Citi says it's constructive on European chemicals ahead of cyclical recovery

BUZZ-Citi says it's constructive on European chemicals ahead of cyclical recovery ** Citi says it is "constructive but not outright bullish" on European chemicals makers, as it weighs the start of a potential volume recovery against structural concerns ** China becoming self-sufficient in chemicals will drive oversupply, the broker warns ** It says Elkem ELK.OL ("neutral") will struggle slightly as the silicones it specialises in are particularly oversupplied ** Citi raises Evonik EVKn.DE to "bu
A
C
L
W

Azelis, Drax Group, Rentokil Initial

EUROPE RESEARCH ROUNDUP-Azelis, Drax Group, Rentokil Initial April 8 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Azelis, Drax Group and Rentokil Initial on Monday. HIGHLIGHTS * Azelis AZE.BR : JP Morgan raises target price to EUR 27 from EUR 25.5 * Drax Group Plc DRX.L : HSBC raises target price to 500p from 470p * Rentokil Initial RTO.L : HSBC cuts target price to 480p from 495p * Volvo AB VOLVb.ST : Jefferies raises to buy fr
A
A
A
A
B
B
B
C
C
C
D
D
E
G
G
H
H
H
K
L
L
L
M
N
P
R
S
S
S
T
V
W
Z
A
A
B
D
F
P
P
S

Jefferies starts Syensqo at 'hold' on risks to earnings progression

BUZZ-Jefferies starts Syensqo at 'hold' on risks to earnings progression ** Jefferies initiates chemicals group Syensqo SYENS.BR with "hold", citing 2023 performance ahead of peers but risks to earnings progression ** Jefferies estimates the company "overearned" peers by 10%-20% last year but expects this to normalize this year ** It flags risks to
A

French and Benelux stocks-Factors to watch

French and Benelux stocks-Factors to watch March 15 (Reuters) - Below are company-related news and stories from France and Benelux which could have an impact on the region's markets or individual stocks. Arkema AKE.PA : Arkema issued a undated hybrid bond of 400 million euros with an annual coupon of 4.8% and a first call date after 5 years. BNP Paribas BNPP.PA : BNP Paribas is considering buying Fosun's Ageas stake, according to Bloomberg News.
A
A
B
B
F
N
U

Arkema Issues A EUR 400 Million Undated Hybrid Bond

BRIEF-Arkema Issues A EUR 400 Million Undated Hybrid Bond March 14 (Reuters) - Arkema SA AKE.PA : ARKEMA SUCCESSFULLY ISSUED A €400 MILLION UNDATED HYBRID BOND ANNUAL COUPON OF 4.8% AND A FIRST CALL DATE AFTER 5 YEARS ANTICIPATES REFINANCING OF ONE OF ITS TWO OUTSTANDING HYBRID BONDS, AMOUNTING TO EUR 400 MILLION AND WITH A FIRST CALL DATE ON 17
A



Conditions

Actifs populaires

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques